Find stats on top websites
Industry Landscape
The biomedical information science industry is dynamic, driven by increasing data generation from research, demanding advanced bioinformatics tools for analysis. Open access and data sharing initiatives are paramount, fueled by public funding and a global research community. The industry is continuously evolving with AI/ML integration for enhanced discovery and accessibility.
Total Assets Under Management (AUM)
NIH Budget in United States
~$47.5 Billion (FY2024 enacted)
(3.5% (FY2024 over FY2023) CAGR)
- Biomedical research funding remains robust.
- Driven by government investment.
- Supports key areas like genomics and public health.
Total Addressable Market
Approximately $250 billion
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Generative AI for Scientific Discovery
Generative AI can accelerate scientific discovery by synthesizing new hypotheses, designing experiments, and generating novel molecular structures based on existing biological data.
Federated Learning for Biomedical Data
Federated learning allows for the analysis of vast, distributed biomedical datasets without centralizing sensitive patient information, enhancing privacy and data accessibility.
Knowledge Graphs for Biomedical Information
Knowledge graphs integrate disparate biomedical data sources into a unified, semantically rich framework, enabling more intuitive exploration and discovery of complex relationships.
Impactful Policy Frameworks
NIH Data Management and Sharing Policy (Effective January 25, 2023)
This NIH policy requires all researchers funded by NIH to submit a Data Management and Sharing Plan outlining how scientific data will be managed and shared, promoting open science and reproducibility.
This policy directly increases the volume and diversity of data shared with NCBI, necessitating robust infrastructure and tools for data ingestion, curation, and accessibility.
21st Century Cures Act (2016) - Information Blocking Provisions (Effective April 5, 2021)
The 21st Century Cures Act aims to accelerate medical product development and requires the interoperability of electronic health information, prohibiting 'information blocking' by health IT vendors, providers, and developers.
This regulation indirectly supports NCBI's mission by encouraging greater data flow and interoperability within the broader biomedical ecosystem, potentially leading to more integrated public datasets.
NIST Privacy Framework (Version 1.0, January 2020)
Developed by the National Institute of Standards and Technology (NIST), this voluntary framework provides a common language and systematic approach for organizations to identify and manage privacy risks.
While not a direct regulation, its increasing adoption influences data handling best practices, pressuring NCBI to continuously enhance its privacy and security measures for sensitive biomedical data.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
